Literature DB >> 2870093

Psychotropic drugs in dermatology. A review and guidelines for use.

M A Gupta, A K Gupta, H F Haberman.   

Abstract

A review of the literature on the use of psychotropic drugs in dermatologic practice--including the antipsychotic, antidepressant, antianxiety, and hypnotic medications, as well as their pharmacologic properties, guidelines for clinical use, and a profile of adverse effects--is presented. After adverse effects and current guidelines for use are taken into consideration, it is suggested that psychotropic drugs be restricted to dermatologic conditions with clearly discernible psychiatric symptoms, for example, psoriasis and major depression, vitiligo resulting in social anxiety, and delusions of parasitosis. The pharmacologic properties of psychotropic drugs, such as the analgesic properties of certain antidepressants, may be of benefit in the treatment of dermatologic symptoms such as intractable pruritus, since pain and pruritus share the same central nervous system pathways. This use of psychotropic drugs remains to be evaluated by well-designed clinical trials.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870093     DOI: 10.1016/s0190-9622(86)70081-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  Increased processing of SINE B2 ncRNAs unveils a novel type of transcriptome deregulation in amyloid beta neuropathology.

Authors:  Yubo Cheng; Luke Saville; Babita Gollen; Christopher Isaac; Abel Belay; Jogender Mehla; Kush Patel; Nehal Thakor; Majid H Mohajerani; Athanasios Zovoilis
Journal:  Elife       Date:  2020-11-16       Impact factor: 8.140

2.  Psychodermatology: a guide to understanding common psychocutaneous disorders.

Authors:  Mohammad Jafferany
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

3.  Use of psychiatric drugs in Dermatology.

Authors:  Magda Blessmann Weber; Júlia Kanaan Recuero; Camila Saraiva Almeida
Journal:  An Bras Dermatol       Date:  2020-02-18       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.